Intravenous Chelators in Lead-Burdened Type 2 Diabetic Nephropathy

Based on previous basic experiments revealing that patients with type 2 diabetic nephropathy exhibit higher blood lead levels than the general population, this study aims to systematically evaluate the impacts of short-term and long-term blood lead exposure on renal function progression in such patients, so as to provide novel epidemiological evidence for clinical intervention.

NCT Number	NCT07706946
Lead Sponsor	The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Conditions	Lead-Burdened Type 2 Diabetic Nephropathy
Enrollment	42 participants
Start Date	2026-08-01
Primary Completion	2029-01-01 (estimated)
Study Completion	2029-01-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-16